Kronox Lab Sciences Limited
Kronox Lab Sciences Limited (KRONOX) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
kronoxlabsciences.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 26 Cr | 24 Cr | 26 Cr |
| Operating expenses (approx.) | 18 Cr | 16 Cr | 17 Cr |
| EBITDA | 8 Cr | 8 Cr | 9 Cr |
| OPM % | 29.7% | 32.8% | 33.9% |
| Other income | 0.91 Cr | 0.87 Cr | 1 Cr |
| Interest | 0 Cr | 0 Cr | 0.04 Cr |
| Depreciation | 0.35 Cr | 0.40 Cr | 0.47 Cr |
| Profit before tax | 8 Cr | 8 Cr | 9 Cr |
| Tax % | 24.0% | 25.6% | 27.3% |
| Net profit | 6 Cr | 6 Cr | 7 Cr |
| EPS (₹) | ₹1.72 | ₹1.70 | ₹1.82 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 100 Cr | Sign in for TTM |
| Operating expenses (approx.) | 67 Cr | Sign in for TTM |
| EBITDA | 33 Cr | Sign in for TTM |
| OPM % | 33.1% | Sign in for TTM |
| Other income | 3 Cr | Sign in for TTM |
| Interest | 0 Cr | Sign in for TTM |
| Depreciation | 1 Cr | Sign in for TTM |
| Profit before tax | 34 Cr | Sign in for TTM |
| Tax % | 26.2% | Sign in for TTM |
| Net profit | 25 Cr | Sign in for TTM |
| EPS (₹) | ₹6.91 | Sign in for TTM |
| Dividend payout % | 7.3% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 37 Cr |
| Reserves | 53 Cr |
| Borrowings | — |
| Other liabilities | 9 Cr |
| Total liabilities | 99 Cr |
| Fixed assets (net) | 28 Cr |
| CWIP | 0.76 Cr |
| Investments | 0.03 Cr |
| Inventories | 6 Cr |
| Trade receivables | 20 Cr |
| Cash & bank | 3 Cr |
| Other assets | 41 Cr |
| Total assets | 99 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 32 Cr |
| Cash from investing | -30 Cr |
| Cash from financing | -2 Cr |
| Net cash flow | 0.45 Cr |
| Free cash flow (OCF − Capex) | 29 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 38.0% |
| ROE % | 28.1% |
| Debtor days | 72 |
| Inventory days | 48 |
| Days payable | 0 |
| Cash conversion cycle | 120 |
| Debt / equity | — |
| Current ratio | 102.04 |
| Net debt / EBITDA | -0.09 |
Compare with peers
Loading peers…